Ganirelix Acetate
Back to searchMolecule Structure
Scientific Name
Ganirelix Acetate
Description of the Drug
Ganirelix is a GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB06785
http://www.drugbank.ca/drugs/DB06785
Brand Name(s)
Ganirelix acetate, Ganirelix Acetate Injection, Orgalutran
Company Owner(s)
Organon Usa Inc, Sun Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19712192 | ||
| WDI | RS-26306 | ||
| DrugBank | DB06785 | ||
| PubChem: Thomson Pharma | 14793014 | ||
| PubChem | 16130957 | ||
| Nikkaji | J419.572H | ||
| BindingDB | 50102454 | ||
| DrugCentral | 1279 | ||
| ChemicalBook | CB62130570 | CB61370494 | CB9775895 |
| GSRS | d04318a1-cafc-476d-b9ca-d606ae8c0a0b | ||
| rxnorm | GANIRELIX | GANIRELIX ACETATE | |
| ChEBI | 135910 |
